The University of Chicago Header Logo

Connection

Kenneth Cohen to Humans

This is a "connection" page, showing publications Kenneth Cohen has written about Humans.
Connection Strength

0.738
  1. A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma. Clin Cancer Res. 2023 12 15; 29(24):5031-5037.
    View in: PubMed
    Score: 0.027
  2. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908. Neuro Oncol. 2023 08 03; 25(8):1530-1545.
    View in: PubMed
    Score: 0.026
  3. Comparison of Care Quality Metrics in 2-Sided Risk Medicare Advantage vs Fee-for-Service Medicare Programs. JAMA Netw Open. 2022 12 01; 5(12):e2246064.
    View in: PubMed
    Score: 0.025
  4. Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine. Nat Commun. 2022 05 02; 13(1):2377.
    View in: PubMed
    Score: 0.024
  5. Use of evidence and technology to improve quality and eliminate low-value care. Am J Manag Care. 2022 02; 28(2):51-52.
    View in: PubMed
    Score: 0.024
  6. Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). J Clin Apher. 2022 Feb; 37(1):117-121.
    View in: PubMed
    Score: 0.023
  7. An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity. J Neurooncol. 2021 May; 152(3):567-572.
    View in: PubMed
    Score: 0.022
  8. Efficacy and Safety of Mechanical IVC Filtration for Preventing Pulmonary Embolism in High-Risk Orthopedic Patients Undergoing Total Hip or Knee Arthroplasty. J Arthroplasty. 2021 07; 36(7):2586-2590.
    View in: PubMed
    Score: 0.022
  9. Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol. 2017 Aug 01; 19(8):1025-1034.
    View in: PubMed
    Score: 0.017
  10. Management of pediatric and adult patients with medulloblastoma. Curr Treat Options Oncol. 2014 Dec; 15(4):581-94.
    View in: PubMed
    Score: 0.014
  11. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model. Clin Cancer Res. 2013 Sep 01; 19(17):4553-8.
    View in: PubMed
    Score: 0.013
  12. Native American healing: a license to practice? Explore (NY). 2013 Jul-Aug; 9(4):203-5.
    View in: PubMed
    Score: 0.013
  13. Is low and slow the way to go? Metronomic therapy in the treatment of pediatric brain tumors. CNS Oncol. 2013 May; 2(3):211-3.
    View in: PubMed
    Score: 0.013
  14. Circulating CD31+ leukocyte frequency is associated with cardiovascular risk factors. Atherosclerosis. 2013 Jul; 229(1):228-33.
    View in: PubMed
    Score: 0.013
  15. A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro Oncol. 2013 Jun; 15(6):783-7.
    View in: PubMed
    Score: 0.013
  16. Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. Blood. 2013 Feb 21; 121(8):e50-6.
    View in: PubMed
    Score: 0.013
  17. Angiogenesis and multiple myeloma: is there a role for angiogenic biomarkers in the context of autologous stem cell transplant? Leuk Lymphoma. 2011 Jul; 52(7):1173-5.
    View in: PubMed
    Score: 0.011
  18. Medulloblastoma with myogenic differentiation: long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation. J Neurooncol. 2011 Dec; 105(3):659-62.
    View in: PubMed
    Score: 0.011
  19. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011 Mar; 13(3):317-23.
    View in: PubMed
    Score: 0.011
  20. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol. 2011 Apr; 13(4):410-6.
    View in: PubMed
    Score: 0.011
  21. Visante OCT measurement of central corneal thickness following Descemet's stripping endothelial keratoplasty. Ophthalmic Surg Lasers Imaging. 2010 Dec 01; 41 Online:e1-3.
    View in: PubMed
    Score: 0.011
  22. Visanteā„¢ OCT measurement of central corneal thickness following Descemet's stripping endothelial keratoplasty. Ophthalmic Surg Lasers Imaging. 2010 Dec 01; 41 Online:e1-3.
    View in: PubMed
    Score: 0.011
  23. Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol. 2009 Dec; 148(6):895-901.e1.
    View in: PubMed
    Score: 0.010
  24. At the canyon's edge: depression in American Indian culture. Explore (NY). 2008 Mar-Apr; 4(2):127-35.
    View in: PubMed
    Score: 0.009
  25. Autologous stem cell rescue in children with brain tumors: the questions mount. Pediatr Blood Cancer. 2008 Feb; 50(2):191.
    View in: PubMed
    Score: 0.009
  26. A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL. Blood Adv. 2025 Nov 11; 9(21):5665-5675.
    View in: PubMed
    Score: 0.008
  27. Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 Mar; 23(3):113-130.
    View in: PubMed
    Score: 0.007
  28. Retinal thickness measurement after phacoemulsification. J Cataract Refract Surg. 2004 Jul; 30(7):1501-6.
    View in: PubMed
    Score: 0.007
  29. Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30600.
    View in: PubMed
    Score: 0.007
  30. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial. Clin Infect Dis. 2023 02 08; 76(3):e1-e9.
    View in: PubMed
    Score: 0.006
  31. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2023 04 01; 41(10):1921-1932.
    View in: PubMed
    Score: 0.006
  32. Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 12; 20(12):1339-1362.
    View in: PubMed
    Score: 0.006
  33. Familial, band-shaped, spheroidal keratopathy histopathology in ethnic Chinese siblings. Cornea. 2002 Nov; 21(8):774-7.
    View in: PubMed
    Score: 0.006
  34. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. N Engl J Med. 2022 08 18; 387(7):599-610.
    View in: PubMed
    Score: 0.006
  35. Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstet Gynecol. 2022 09 01; 140(3):477-487.
    View in: PubMed
    Score: 0.006
  36. A data-based foundation for managing hypertension services. Am J Manag Care. 2022 08 01; 28(8):e282-e288.
    View in: PubMed
    Score: 0.006
  37. Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. Haematologica. 2022 07 01; 107(7):1608-1618.
    View in: PubMed
    Score: 0.006
  38. Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. Neuro Oncol. 2022 05 04; 24(5):821-833.
    View in: PubMed
    Score: 0.006
  39. Is there a requirement for adjuvant therapy for choroid plexus carcinoma that has been completely resected? J Neurooncol. 2002 Apr; 57(2):123-6.
    View in: PubMed
    Score: 0.006
  40. The Effect of a Shared Decision-Making Process on Acceptance of Colorectal Cancer Screening. Ann Fam Med. 2022 Jan-Feb; 20(1):89.
    View in: PubMed
    Score: 0.006
  41. Pediatric glial tumors. Curr Treat Options Oncol. 2001 Dec; 2(6):529-36.
    View in: PubMed
    Score: 0.006
  42. Second surgery for recurrent pilocytic astrocytoma in children. Pediatr Neurosurg. 2001 May; 34(5):229-34.
    View in: PubMed
    Score: 0.006
  43. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatr Blood Cancer. 2021 02; 68(2):e28787.
    View in: PubMed
    Score: 0.005
  44. Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol. 2020 06; 21(6):e330-e336.
    View in: PubMed
    Score: 0.005
  45. Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg. 2000 Jan; 32(1):24-9.
    View in: PubMed
    Score: 0.005
  46. Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study. Clin Cancer Res. 2019 12 15; 25(24):7303-7311.
    View in: PubMed
    Score: 0.005
  47. A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors. Clin Cancer Res. 2019 12 15; 25(24):7294-7302.
    View in: PubMed
    Score: 0.005
  48. Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
    View in: PubMed
    Score: 0.005
  49. Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol. 2018 10 09; 20(11):1547-1555.
    View in: PubMed
    Score: 0.005
  50. A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Pediatr Blood Cancer. 2018 09; 65(9):e27217.
    View in: PubMed
    Score: 0.005
  51. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):152-168.
    View in: PubMed
    Score: 0.005
  52. Association of Neuronal Injury in the Genu and Body of Corpus Callosum After Cranial Irradiation in Children With Impaired Cognitive Control: A Prospective Study. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1234-1242.
    View in: PubMed
    Score: 0.005
  53. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol. 2017 Oct 19; 19(11):1542-1552.
    View in: PubMed
    Score: 0.004
  54. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Pediatr Blood Cancer. 2017 Nov; 64(11).
    View in: PubMed
    Score: 0.004
  55. University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL. Br J Haematol. 2018 04; 181(2):264-267.
    View in: PubMed
    Score: 0.004
  56. Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus. J Clin Rheumatol. 2016 Sep; 22(6):320-3.
    View in: PubMed
    Score: 0.004
  57. A prospective study of cerebral, frontal lobe, and temporal lobe volumes and neuropsychological performance in children with primary brain tumors treated with cranial radiation. Cancer. 2017 Jan 01; 123(1):161-168.
    View in: PubMed
    Score: 0.004
  58. Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial Efficiency. J Pediatr Hematol Oncol. 2016 07; 38(5):360-6.
    View in: PubMed
    Score: 0.004
  59. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy. Childs Nerv Syst. 2016 Aug; 32(8):1425-30.
    View in: PubMed
    Score: 0.004
  60. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro Oncol. 2016 10; 18(10):1442-50.
    View in: PubMed
    Score: 0.004
  61. Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas. Eur J Radiol. 2016 Apr; 85(4):700-6.
    View in: PubMed
    Score: 0.004
  62. Identifying early dropouts from a rehabilitation program for psychiatric outpatients. Psychiatr Serv. 1995 Oct; 46(10):1076-8.
    View in: PubMed
    Score: 0.004
  63. Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol. 2014 Aug; 38(8):1058-70.
    View in: PubMed
    Score: 0.004
  64. Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol. 2014 Nov; 16(11):1554-9.
    View in: PubMed
    Score: 0.003
  65. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol. 2014 Oct; 16(10):1408-16.
    View in: PubMed
    Score: 0.003
  66. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J. 2014 Nov 07; 35(42):2972-9.
    View in: PubMed
    Score: 0.003
  67. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet. 2014 May; 46(5):462-6.
    View in: PubMed
    Score: 0.003
  68. Response to Passos et al. Pediatr Neurol. 2014 Feb; 50(2):e3-4.
    View in: PubMed
    Score: 0.003
  69. Apparent diffusion coefficient of pediatric cerebellar tumors: a biomarker of tumor grade? Pediatr Blood Cancer. 2013 Dec; 60(12):2036-41.
    View in: PubMed
    Score: 0.003
  70. Hemorrhagic and ischemic stroke in children with cancer. Pediatr Neurol. 2013 Oct; 49(4):237-42.
    View in: PubMed
    Score: 0.003
  71. Management of pediatric spinal cord astrocytomas: outcomes with adjuvant radiation. Int J Radiat Oncol Biol Phys. 2013 Apr 01; 85(5):1307-11.
    View in: PubMed
    Score: 0.003
  72. Do all candidemic patients need an ophthalmic examination? Int J Infect Dis. 2013 Mar; 17(3):e146-8.
    View in: PubMed
    Score: 0.003
  73. Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro Oncol. 2013 Mar; 15(3):360-9.
    View in: PubMed
    Score: 0.003
  74. Children's Oncology Group's 2013 blueprint for research: central nervous system tumors. Pediatr Blood Cancer. 2013 Jun; 60(6):1022-6.
    View in: PubMed
    Score: 0.003
  75. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Res. 2013 Jan 01; 73(1):184-94.
    View in: PubMed
    Score: 0.003
  76. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol. 2012 Nov; 124(5):627-41.
    View in: PubMed
    Score: 0.003
  77. Management of pediatric myxopapillary ependymoma: the role of adjuvant radiation. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):421-7.
    View in: PubMed
    Score: 0.003
  78. Shared medical decision-making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young children. Pediatr Blood Cancer. 2012 Aug; 59(2):216-20.
    View in: PubMed
    Score: 0.003
  79. Circulating angiogenic cell populations, vascular function, and arterial stiffness. Atherosclerosis. 2012 Jan; 220(1):145-50.
    View in: PubMed
    Score: 0.003
  80. Magnetic resonance imaging features of meningiomas in children and young adults: a retrospective analysis. J Neuroradiol. 2012 Oct; 39(4):218-26.
    View in: PubMed
    Score: 0.003
  81. OCT-documented incision features and natural history of clear corneal incisions used for bimanual microincision cataract surgery. Cornea. 2011 Jun; 30(6):681-6.
    View in: PubMed
    Score: 0.003
  82. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res. 2011 Jun 01; 17(11):3590-9.
    View in: PubMed
    Score: 0.003
  83. Genetic and clinical correlates of early-outgrowth colony-forming units. Circ Cardiovasc Genet. 2011 Jun; 4(3):296-304.
    View in: PubMed
    Score: 0.003
  84. T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse. Leuk Lymphoma. 2011 Feb; 52(2):214-22.
    View in: PubMed
    Score: 0.003
  85. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. Am J Surg Pathol. 2010 Dec; 34(12):1783-91.
    View in: PubMed
    Score: 0.003
  86. Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation. 2010 Sep 21; 122(12):1176-82.
    View in: PubMed
    Score: 0.003
  87. The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma. Blood Cells Mol Dis. 2010 Dec 15; 45(4):317-23.
    View in: PubMed
    Score: 0.003
  88. Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group. J Neurooncol. 2010 Sep; 99(2):155-63.
    View in: PubMed
    Score: 0.003
  89. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol. 2010 Jun 10; 28(17):2817-23.
    View in: PubMed
    Score: 0.003
  90. Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas? Pediatr Blood Cancer. 2010 Apr; 54(4):641-3.
    View in: PubMed
    Score: 0.003
  91. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol. 2010 Aug; 99(1):65-71.
    View in: PubMed
    Score: 0.003
  92. Evaluation of quality improvement initiative in pediatric oncology: implementation of aggressive hydration protocol. J Nurs Care Qual. 2009 Apr-Jun; 24(2):153-9.
    View in: PubMed
    Score: 0.002
  93. Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr. 2009 Apr; 3(4):259-69.
    View in: PubMed
    Score: 0.002
  94. Sixteen-year predictors of substance use disorder diagnoses for patients with mental health disorders. Subst Abus. 2009 Jan-Mar; 30(1):40-6.
    View in: PubMed
    Score: 0.002
  95. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009 Jan 20; 27(3):385-9.
    View in: PubMed
    Score: 0.002
  96. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer. 2008 Aug; 51(2):245-50.
    View in: PubMed
    Score: 0.002
  97. Identification of unknown intraocular material after cataract surgery: evaluation of a potential cause of toxic anterior segment syndrome. J Cataract Refract Surg. 2008 Mar; 34(3):465-9.
    View in: PubMed
    Score: 0.002
  98. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer. 2007 Dec 01; 110(11):2535-41.
    View in: PubMed
    Score: 0.002
  99. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood. 2008 Feb 01; 111(3):1302-5.
    View in: PubMed
    Score: 0.002
  100. Determining factors for corneal endothelial cell loss by using bimanual microincision phacoemulsification and power modulation. Cornea. 2007 Oct; 26(9):1049-55.
    View in: PubMed
    Score: 0.002
  101. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol. 2007 May; 4(5):316-21.
    View in: PubMed
    Score: 0.002
  102. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007 Jan; 11(1):83-95.
    View in: PubMed
    Score: 0.002
  103. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc. 2007; 2(4):805-10.
    View in: PubMed
    Score: 0.002
  104. Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus. J Cataract Refract Surg. 2006 May; 32(5):803-11.
    View in: PubMed
    Score: 0.002
  105. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J Clin Oncol. 2006 Mar 20; 24(9):1449-53.
    View in: PubMed
    Score: 0.002
  106. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging. 2006 Feb; 23(2):99-107.
    View in: PubMed
    Score: 0.002
  107. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood. 2006 Apr 01; 107(7):2774-6.
    View in: PubMed
    Score: 0.002
  108. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol. 2005 Nov 01; 23(31):8136-9.
    View in: PubMed
    Score: 0.002
  109. Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function. Blood. 2005 Mar 01; 105(5):2235-8.
    View in: PubMed
    Score: 0.002
  110. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol. 2004 May; 63(5):441-9.
    View in: PubMed
    Score: 0.002
  111. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004 Feb; 10(2):145-7.
    View in: PubMed
    Score: 0.002
  112. Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol. 2003 Mar; 25(3):198-203.
    View in: PubMed
    Score: 0.002
  113. Identification and characterization of the novel centrosome-associated protein CCCAP. Gene. 2003 Jan 16; 303:35-46.
    View in: PubMed
    Score: 0.002
  114. Recurrence of iris stromal cyst following aspiration and resection. J AAPOS. 2002 Aug; 6(4):255-6.
    View in: PubMed
    Score: 0.002
  115. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol. 2002 Jan; 12(1):36-44.
    View in: PubMed
    Score: 0.001
  116. No responses to oral etoposide in 15 patients with recurrent brain tumors. Med Pediatr Oncol. 2000 Jul; 35(1):80-2.
    View in: PubMed
    Score: 0.001
  117. Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol. 2000 Jul-Aug; 3(4):346-52.
    View in: PubMed
    Score: 0.001
  118. Pathology of diencephalic astrocytomas. Pediatr Neurosurg. 2000 Apr; 32(4):214-9.
    View in: PubMed
    Score: 0.001
  119. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant. 1998 Nov; 22(10):971-9.
    View in: PubMed
    Score: 0.001
  120. Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci U S A. 1994 Jul 19; 91(15):6875-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.